高銀金融(00530.HK)澄清非出售賜譽股權或寫字樓擁有權
高銀金融(00530.HK)公布,董事會留意到,近期若干報道推測公司可能出售賜譽股權及寫字樓物業擁有權、賜譽及寫字樓物業控股權益、公司出售賜譽股權及寫字樓物業之權利,以及委任Knight Frank LLP(萊坊)。
公司現澄清,建議交易計劃轉讓成美及Goal Eagle股權,並非出售賜譽股權或寫字樓物業擁有權。目前公司間接附屬公司賜譽擁有權,受進行中之法律程序及法院就賜譽申請的裁決所規限。
公司強調,建議交易目前有待法院批准,為完成建議交易的先決條件。經作出合理查詢後,概不知悉任何委任萊坊為寫字樓物業獨家銷售代理的事宜,亦無就建議進行交易委任萊坊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.